Ausgewählte Publikationen

Stegemann J, Baer FM, Hoffmann U. The valsalva Maneuver as an indirect, non-invasive indicator of central blood volume shift. 
Aviat. Space Environ. Med. 1988; 59:422-427.

Baer FM, Smolarz K, Jungehülsing M, Theissen P, Sechtem U, Schicha H, Hilger HH. Feasibility of High-Dose Dipyridamole MRI for detection of coronary artery disease and comparison with coronary angiography. 
Am J Cardiol 1992; 69:51-56.

Baer FM, Smolarz K, Theissen P, Voth E, Schicha H, Sechtem U. Assessment of myocardial viability by quantification of of 99mTc-methoxyisobutyl-isonitrile uptake at rest: comparison with parameters of myocardial viability obtained from gradient-echo nuclear magnetic resonance imaging. 
Eur Heart J 1994; 15:97-107.

Baer FM, Voth E, Theissen P, Schicha H, Sechtem U. Identification of functionally significant coronary artery stenoses by dobutamine gradient-echo magnetic resonance imaging and comparison to coronary angiography. 
Eur Heart J 1994; 15:218-225.

Baer FM, Voth E, Theissen P, Schneider CA, Schicha H, Sechtem U. Comparison of dobutamine-magnetic resonance imaging and dobutamine-99mTc-methoxy-isobutyl-isonitrile SPECT in the diagnosis of coronary artery disease. 
Radiology 1994; 193:203-209.

Baer FM, Voth E, Deutsch H, Schneider CA, Schicha H, Sechtem U. Assessment of viable myocardium by dobutamine-transesophageal-echocardiography (TEE) and comparison with FDG-positron emission tomography. 
J Am Coll Cardiol 1994; 24:343-353.

Baer FM, Voth E, Schneider CA, Theissen P, Schneider CA, Schicha H, Sechtem U. Dobutamine-gradient echo MRI: a functional and morphologic apprroach to the detection of residual myocardial viability. 
Circulation 1995; 91:1006-15.

Baer FM, Voth E, Deutsch H, Schneider CA, Horst M, deVivie ER, Schicha H, Erdmann E, Sechtem U. Predictive value of low-dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for the recovery of regional left ventricular function after successful revascularization.
J Am Coll Cardiol 1996; 28:60-9.

Baer FM, Voth E, LaRosee K, Schneider CA, Theissen P, Deutsch HJ, Schicha H, Erdmann E, Sechtem U. Comparison of dobutamine-transesophageal echocardiography and dobutamine-magnetic resonance imaging for the detection of residual myocardial viability.
Am J Cardiol 1996; 78:415-419. 

Schneider CA, Voth E,  Baer FM, Horst M, Wagner R, Sechtem U. QT dispersion is determined by the extent of viable myocardium in patients with chronic Q- wave myocardial infarction.
Circulation 1997;96:3913-3920.

Schneider CA, Voth E, Gawlich S, Baer FM, Horst M, Schicha H, Erdmann E, Sechtem U. Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q-wave myocardial infarction: importance of infarct location adjusted thresholds.
J Am Coll Cardiol 1998;32:648-654.

Marwick T, Brunken R, Meland N, Brochet E, Baer FM, Binder T, Flachskampf F, Kamp O, Nienhaber C, Nihoyannopoulos P, Pierard L, Vanoverschelde JL, Wouw P, Lindvall K. Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice.: comparison with wall motion and MIBI-SPECT. 
J Am Coll Cardiol 1998;32:1260-1269.

Baer FM, Theissen P, Schneider CA, Voth E, Sechtem U, Schneider CA, Schicha H, Erdmann E. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. 
J Am Coll Cardiol 1998; 31:1040-1048.

Baer FM, Theissen P, Crnac J, Schmidt M, Deutsch HJ, Sechtem U, Schicha H, Erdmann E. Head-to-head comparison of dobutamine-transesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease.
Eur Heart J 2000; 21:981-991.

Höpp HW, Baer FM, Özbek C, Kuck KH, Scheller B. A synergistic approach to optimal stenting: directional atherectomy (DCA) prior to coronary artery stent implantation - the Atherolink registry.
J Am Coll Cardiol 2000; 36:1853-9.
    
Moka D, Baer FM, Theissen P, Schneider CA, Dietlein M, Erdmann E, Schicha H. Non-Q-wave myocardial infarction: impaired myovardial enegy metabolism in regions with reduced Tc-MIBI accumulation.
Eur J Nucl Med  2001;28:602-607.

Schneider T, Theissen P, Höpp HW, Baer FM. Treatment of diffuse in-stent-restenosis by rhenium-188 brachytherapy.
Am Heart J 2007; 13:114-119.

Baumgart D, Klauss F, Baer FM et al. One Year Results of the SCORPIUS-Study – A  German Multicenter Investigation on the Effectiveness of Sirolimus Eluting Stents in Diabetic Patients. 
J Am Coll Cardiol  2007;50:1627-34.

Roessig L, Genth-Zotz S, Rau M, Hendrickx GR, Baer FM, Gulba DC, Zeiher AM. Argatroban anticoagulation for PCI: the E=04 European multicenter study. 
Circulation 2007;116:617-28.

Sinning JM, Baumgart D, Werner N, Klauss V, Baer FM, Hartmann F, Drexler H, Motz W, Klues H, Voelker W. Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: A German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients.
Am Heart J 2012;163:446.

Weiss M, Michels G, Eberhardt  F,  Fehske W, Winter S, Baer FM, Choi YH, Albus C, Steven D, Baldus S, Pfister R. Anxiety, depression and quality of life in acute high risk cardiac disease patients eligible for wearable cardioverter defibrillator: Results from the prospective multicenter CRED-registry
Plos One 2019; DOI: 10.1371/journal.pone.0213261.